Submissions

Author Guidelines

1. Submission of Manuscript:

Authors should submit electronic version (Microsoft Word .doc or .docx) of the manuscript through online submission.

Accepted papers will be acknowledged and processed further if the papers are rejected, the decision will be communicated to the corresponding author but the manuscripts will not be returned.
Acceptance or rejection of the manuscript would be decided after the decision of the editorial team.
Acceptance or rejection of the manuscript for publication in the journal would be informed to the corresponding author shortly from the date of submission.

Copyright form: Upon acceptance of an article, authors will be asked to transfer copyright. This transfer will ensure the widest possible dissemination of information.

Informed Consent

The papers comply with the clinical trials informed consent should be obtained from the participants or human healthy volunteers or Patients or in the case of minors the consent should be obtained from the parents. This should be indicated in the article in the method section.

Ethics

Studies reporting the experiments on human subjects and animals, procedures should be followed standard guidelines and authors should indicate whether the procedures followed as the guidelines and ethical standards. The study should be obtained the ethical clearances from the ethical committee. The author should indicate the ethical clearance number or project /proposal approval number in the method section. If needed by the journal editorial board the authors should produce the copy of ethical clearance.

2. Preparing a Manuscript:

Manuscripts should be prepared as word processing documents on A4, or Letter size paper, leaving a liberal margin (2 cm) on all four sides which should be in single-column format. The manuscript should be typed single-spaced throughout including references and tables. All figures and tables should be in the text. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, use a plane table.

Fonts: Times New Roman and point size should be 12.

File Size: 2MB (if more than 2 MB split image and figures as supplementary file)

Authors should keep their manuscripts as short as they reasonably can (the total number of words should not exceed 3200). The page number should appear in the upper right-hand corner of each page, beginning with the title page. The language of the manuscript must be simple and explicit. Author's / Co-author's name or any other identification should not appear anywhere in the body of the manuscript to facilitate blind review.

We accept manuscript under following categories: Original Research Articles, Review, Short communications, Case reports, Letter to Editor.

Original Research Articles: It should be arranged into the following sections:

Title page: (Upload as supplementary file to follow blind review)

It should carry the title, author(s) names and their affiliations, running title, address for correspondence including e-mail address.

Title: Must be informative, specific and short and not exceed 100 characters.

Running Title: Must be informative, specific and short and not exceed 50 characters.

Authors and affiliations: The names of authors and their appropriate addresses, along with individual mail id should be given. It should be made clear which address relates to which author.

Address for correspondence: The corresponding author's address should be given on the title page. The fax number (if available) may be mentioned. The e-mail ID of the corresponding author or the contact e-mail ID must also be provided.

Acknowledgements
It should be typed on a new page. Acknowledge only persons who have contributed to the scientific content or provided technical support. Sources of financial support should be mentioned.

Subdivision - numbered sections:

Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2 ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to "the text". Any subsection may be given a brief heading. Each heading should appear on its own separate line.

Abstract and keywords

It must start on a new file carrying the following information:

(a) Title (without authors names or affiliations)

(b) Abstract body- It should not exceed 250 words excluding the title and the keywords. The abstract must be concise, clear and informative rather than indicative. The abstract must be in a structured form consisting of objectives, methods, results, and conclusions briefly explaining what was intended, done, observed and concluded. Authors should state the main conclusions clearly and not in vague statements. The conclusions and recommendations not found in the text of the article should not be given in the abstract.
(c) Keywords- Provide 3-5 keywords which will help readers or indexing agencies in cross-indexing the study. The words found in the title need not be given as keywords.

Introduction

(All headings: Lowercase and bold, Reference numbers should be cited square bracket [ ]), (Times New Roman 12 font size)

It should start on a new page. Essentially this section must introduce the subject and briefly say how the idea for research originated. Give a concise background of the study. Do not review literature extensively but provide the most recent work that has a direct bearing on the subject. A justification for research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the study should be stated at the end. It should not exceed 500 words.

Material and Methods

(All sub-headings: Lowercase and bold, Reference numbers should appear square bracket [ ]), (Times New Roman 12 font size)

This section should deal with the materials used and the methodology - how the work was carried out. The procedure adopted should be described in sufficient detail to allow the study to be interpreted and repeated by the readers, if necessary. The number of subjects, the number of groups studied, the study design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical aspects must be mentioned under the section. The methodology - the data collection procedure - must be described in sufficient detail. If a procedure is a commonly used one, giving a reference (previously published) would suffice. If a method is not well known (though previously published) it is better to describe it briefly. Give explicit descriptions of modifications or new methods so that the readers can judge their accuracy, reproducibility, and reliability.

The nomenclature, the source of material and equipment used, with details of the manufacturers in parentheses, should be clearly mentioned. Drugs and chemicals should be precisely identified using their non-proprietary names or generic names. If necessary, the proprietary or commercial name may be inserted once in parentheses. In case of pharmaceuticals, the first letter of the drug name should be small for generic name (e.g., dipyridamole, propranolol) but capitalized for proprietary names (e.g., Persantin, Inderal). The routes of administration may be abbreviated, e.g., intraarterial (i.a.), intracerebroventricular (i.c.v.), intra-gastric lavage (i.g.), intramuscular (i.m.), intraperitoneal (i.p.), intravenous (i.v.), per os (p.o.), subcutaneous (s.c.), transdermal (t.d.).

Statistical Methods

The details of statistical tests used and the level of significance should be stated. If more than one test is used it is important to indicate which groups and parameters have been subjected to which test.

Results

(All sub-headings: Lowercase and bold, Reference numbers should appear in square bracket [ ]), (Times New Roman 12 font size)

The results should be stated concisely without comments. It should be presented in logical sequence in the text with appropriate reference to tables and/or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables. Avoid discussions and conclusions in the results section.

Discussion

(All sub-headings: Lowercase and bold; Reference numbers should appear in square bracket [ ]), (Times New Roman 12 font size)

This section should deal with the interpretation, rather than a recapitulation of results. It is important to discuss the new and significant observations in the light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth.

Avoid unqualified statements and conclusions not completely supported by the data. Repetition of information given under Introduction and Results should be avoided. Conclusions must be drawn considering the strengths and weaknesses of the study. They must be conveyed in the last paragraph under Discussion. Make sure conclusions drawn should tally with the objectives stated under Introduction.

References

(Reference numbers should appear in square bracket [ ]), (Times New Roman 12 font size)

It should begin on a new page. Avoid citing abstracts as references.

Papers which have been submitted and accepted but not yet published may be included in the list of references with the name of the journal and indicated as "In press". A photocopy of the acceptance letter should be submitted with the manuscript. Information from manuscript submitted but not yet accepted should not be included.

The unpublished observations and personal communications may not be used as references but may be inserted (in parentheses) in the text.

References are to be cited in the text by number in square bracket [ ]